Clinical results matter

1.Feasibility Study: StrataMGT in improving the symptoms of various vulvovaginal conditions

Hall, P. (2024). Women‘s Health Reports, 5(1), 444-452.

A 52-women open-label, single-arm intervention study was conducted in St. Andrews War Memorial Hospital (Brisbane, Australia) to evaluate the efficacy and safety of StrataMGT for the management of genital skin conditions.
Patients were diagnosed with Vaginal atrophy (VA), mean age of 66.3 (range 50 - 74 years); Lichen Sclerosus (LS) and Lichen Simplex Chronicus (LSC), mean age of 54.7 (range 19 - 81 years).

Results:
The most significant improvements were seen during the first 6 weeks, where symptoms improved up to a 100% resolution for some patients. Favorable results were maintained over 2 years post start of the treatment.

  • Treatment compliance was very high, between 86% and 97% in each visit interval. No adverse events were observed.
  • StrataMGT is a suitable alternative treatment for women suffering from various highly symptomatic vulvovaginal conditions.
2. Dr. Philip Edward Hall

Poster presented on 22nd Annual Australasian Menopause Society Congress (2018).

Case series to test the efficacy of StrataMGT on patients presenting for treatment of chronic uncontrolled vulvovaginal conditions, such as Vaginal atrophy (VA) and Lichen Sclerosus (LS). Patients were followed up over 3 visits (V1-3), averaging 6 week intervals. Patients mean age of 53.5 (range 30 - 77 years).

Results:
The most significant improvement was seen for all patients within the first 6 weeks, where symptoms improved from 33% through to 100% resolution in some patients.

  • StrataMGT provides hydration whilst protecting the epithelium and mucosa from irritants such as urine, infection and friction.
3. Dr. Marc Winter

Data on file, 2022. (Orange Coast Womens Medical Group, USA). Stratpharma AG.

A non-uncontrolled, open-label intervention study was conducted in Orange Coast Women‘s Medical Group (Laguna Hills, California, USA), to evaluate the efficacy and safety of StrataMGT and the improvement of patient‘s Quality of Life (QoL). All patients were postmenopausal, diagnosed with VA, and treated with StrataMGT for 2 months.

Observations:
The most significant improvement was seen during the first month of treatment - the VQLI score was reduced by 54%.

  • StrataMGT is highly efficient in reducing clinical symptoms associated with Vaginal atrophy and improving QoL.


* Patients rated the impact of vulvar conditions on QoL using Vulvar Quality of Life Index (VQLI) ranging from 0=not impacted, 1-15=mildly impacted, 16-30=moderately impacted, 31-45=severely impacted​

GUIDED BY RESEARCH

designed for comfort
backed by science

“StrataMGT consists of advanced medical grade silicone polymers that are hydrophobic and semi-occlusive, allowing for the exchange of gases through the epithelium and reducing moisture loss.

StrataMGT provides hydration whilst protecting the epithelium and mucosa from irritants such as infection and friction. Clinical trials suggest StrataMGT provides resolution of symptoms without the need for constant potent topical steroid or hormonal preparations.”

Dr. Philip Hall, MBBS, MRMed, FRANZCOG, FRCOG, FACRRM
Gynaecologist and Reconstructive Surgeon
The Pelvic Medicine Centre, Brisbane Australia

IMS world congress on Menopause

At the IMS Melbourne 2024 conference, key findings on StrataMGT were presented at a symposium dedicated to advances in the management of vulvovaginal conditions. Highlights include:

  • Dr. Andrew T. Goldstein: A study on vulvar lichen sclerosus (LS) demonstrating reduced inflammation and significant improvement in symptoms, including decreased itching and pain.
  • Dr. Marc Winter: A comparison between StrataMGT and a hormonal cream for genital-urinary syndrome of menopause (GSM), showing comparable efficacy and better tolerance for StrataMGT.
  • Dr. Philip Hall: A study on the use of StrataMGT as an adjunctive therapy for chronic conditions such as chronic lichen simplex (CLS), GSM, and LS, reporting sustained improvement in symptoms without side effects.


YOU CAN VIEW THE POSTERS HERE:

Dr. Philip Hall, Poster

Dr. Philip Hall, Poster

A Feasibility Study Investigating a Topical Preparation as Novel Adjunct Treatment for the Symptomatic Management of Vulvovaginal Skin Conditions

View

Dr. Philip Hall, Poster

A Feasibility Study Investigating a Topical Preparation as Novel Adjunct Treatment for the Symptomatic Management of Vulvovaginal Skin Conditions

Dr. Marc Winter Poster

Dr. Marc Winter Poster

Non-inferiority trial comparing novel non-hormonal wound dressing to estrogen topical cream for treatment of Genitourinary Syndrome of Menopause

View

Dr. Marc Winter Poster

Non-inferiority trial comparing novel non-hormonal wound dressing to estrogen topical cream for treatment of Genitourinary Syndrome of Menopause

Dr. Andrew T. Goldstein Poster

Dr. Andrew T. Goldstein Poster

StrataMGT for the Treatment of Vulvar Lichen Sclerosus

View

Dr. Andrew T. Goldstein Poster

StrataMGT for the Treatment of Vulvar Lichen Sclerosus

Symposium Video

Become an ambassador for women's well-being by taking part in our clinical trials

Stratpharma is currently recruiting for two clinical trials in the United States and the rest of the world:

Site: Multi-center
Clinical Trials.gov ID: NCT05953090

Site: Orange Coast Women's Medical Group (CA)
Clinical Trials.gov ID: NCT05672901

Site: Centers for Vulvovaginal Disorder, New York 10036
Clinical Trials.gov ID: NCT06360705

Site: Multi-center
Clinical Trials.gov ID: NCT06662942

Why participate?

Access to a product for all types of vaginal conditions

You'll have access to StrataMGT, which helps support women's intimate health without hormones, steroids and side effects.

Close medical supervision

You will benefit from close medical supervision by a team of professionals.

Contribute to StrataMGT's effectiveness

You'll take part in the development of StrataMGT and help other women discover this innovative gel so they can finally find relief for their symptoms.

Knowledge acquisition

You will acquire knowledge and increased awareness of your condition and general health, enabling you to become a true ambassador of feminine well-being.

HEALTHCARE PROVIDER OPPORTUNITIES: DISCOVER STRATAMGT BENEFITS

Offer your patients the unique opportunity to discover how StrataMGT can help them manage all types of vaginal conditions.

Discover the Authorized Healthcare Provider discount program​

Inform your HCP about the Stratpharma Authorized Providers Discount, so that they can contact us and offer you and other women an additional discount on all your orders when using their unique code for purchase from the webshop.​

Healthcare Provider opportunities: Request samples​

If you are a healthcare provider, fill out the form to request StrataMGT samples for your clinic or center​.

I am a HCP and want samples for my patients I am a HCP and want to know more about the discount program.​

Discuss with our medical team

If you would like to take part in one of our clinical trials, or if you have any other questions, please don't hesitate to contact us! Our medical team will be delighted to answer your questions.